Cargando…

(821) Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following Third Dose of COVID-19 MRNA Vaccination

INTRODUCTION: Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccinations. The frequency of the event was reported 2-3 cases per million vaccinations. Clinical courses remain variable, ranging from asymptomatic to severe heart failu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamaya, T., Sato, T., Kobayashi, Y., Mori, Y., Kamiya, K., Otsuka, N., Nagai, T., Anzai, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068045/
http://dx.doi.org/10.1016/j.healun.2023.02.834
_version_ 1785018603252219904
author Hamaya, T.
Sato, T.
Kobayashi, Y.
Mori, Y.
Kamiya, K.
Otsuka, N.
Nagai, T.
Anzai, T.
author_facet Hamaya, T.
Sato, T.
Kobayashi, Y.
Mori, Y.
Kamiya, K.
Otsuka, N.
Nagai, T.
Anzai, T.
author_sort Hamaya, T.
collection PubMed
description INTRODUCTION: Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccinations. The frequency of the event was reported 2-3 cases per million vaccinations. Clinical courses remain variable, ranging from asymptomatic to severe heart failure requires mechanical circulatory supports (MCS). Here we report a case of fulminant myocarditis requiring MCS following COVID-19 mRNA vaccination. CASE REPORT: A 22-year-old male presented to the hospital with chest pain and fever 2 days after receiving the third dose of the COVID-19 mRNA vaccination. Electrocardiography showed tachycardia with ST-segment elevation. Inflammatory and myocardial injury markers were elevated, and echocardiography demonstrated slight left ventricular (LV) dysfunction. He was hospitalized for suspecting acute myocarditis. On the second day of hospitalization, he developed recurrent ventricular fibrillation with cardiogenic shock leading to need for venoarterial extracorporeal membrane oxygenation and intra-aortic balloon pumping. Echocardiography revealed severe LV systolic dysfunction. Catheter examinations showed normal coronary with elevated right and left sided filling pressures and decreased cardiac output. Endomyocardial biopsy (EMB) revealed moderate endomyocardial thickening, mild inflammation, increased interstitial fibrosis and cell infiltration with more macrophages (CD68+) (Figure) (awaiting the results of tenascin-C, angiotensin converting enzyme 2 and severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] spike S protein). No viral genomes including SARS-CoV-2 were detected in the EMB specimens by polymerase chain reaction test. With advanced therapy, he was discharged on the 26th day without any cardiac dysfunction. SUMMARY: Histological evaluation is important for diagnosing myocarditis following COVID-19 vaccination to confirm type of inflammation and the absence of viral genomes.
format Online
Article
Text
id pubmed-10068045
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-100680452023-04-03 (821) Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following Third Dose of COVID-19 MRNA Vaccination Hamaya, T. Sato, T. Kobayashi, Y. Mori, Y. Kamiya, K. Otsuka, N. Nagai, T. Anzai, T. J Heart Lung Transplant Article INTRODUCTION: Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccinations. The frequency of the event was reported 2-3 cases per million vaccinations. Clinical courses remain variable, ranging from asymptomatic to severe heart failure requires mechanical circulatory supports (MCS). Here we report a case of fulminant myocarditis requiring MCS following COVID-19 mRNA vaccination. CASE REPORT: A 22-year-old male presented to the hospital with chest pain and fever 2 days after receiving the third dose of the COVID-19 mRNA vaccination. Electrocardiography showed tachycardia with ST-segment elevation. Inflammatory and myocardial injury markers were elevated, and echocardiography demonstrated slight left ventricular (LV) dysfunction. He was hospitalized for suspecting acute myocarditis. On the second day of hospitalization, he developed recurrent ventricular fibrillation with cardiogenic shock leading to need for venoarterial extracorporeal membrane oxygenation and intra-aortic balloon pumping. Echocardiography revealed severe LV systolic dysfunction. Catheter examinations showed normal coronary with elevated right and left sided filling pressures and decreased cardiac output. Endomyocardial biopsy (EMB) revealed moderate endomyocardial thickening, mild inflammation, increased interstitial fibrosis and cell infiltration with more macrophages (CD68+) (Figure) (awaiting the results of tenascin-C, angiotensin converting enzyme 2 and severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] spike S protein). No viral genomes including SARS-CoV-2 were detected in the EMB specimens by polymerase chain reaction test. With advanced therapy, he was discharged on the 26th day without any cardiac dysfunction. SUMMARY: Histological evaluation is important for diagnosing myocarditis following COVID-19 vaccination to confirm type of inflammation and the absence of viral genomes. Published by Elsevier Inc. 2023-04 2023-04-03 /pmc/articles/PMC10068045/ http://dx.doi.org/10.1016/j.healun.2023.02.834 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Hamaya, T.
Sato, T.
Kobayashi, Y.
Mori, Y.
Kamiya, K.
Otsuka, N.
Nagai, T.
Anzai, T.
(821) Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following Third Dose of COVID-19 MRNA Vaccination
title (821) Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following Third Dose of COVID-19 MRNA Vaccination
title_full (821) Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following Third Dose of COVID-19 MRNA Vaccination
title_fullStr (821) Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following Third Dose of COVID-19 MRNA Vaccination
title_full_unstemmed (821) Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following Third Dose of COVID-19 MRNA Vaccination
title_short (821) Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following Third Dose of COVID-19 MRNA Vaccination
title_sort (821) biopsy-proven fulminant myocarditis requiring mechanical circulatory support following third dose of covid-19 mrna vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068045/
http://dx.doi.org/10.1016/j.healun.2023.02.834
work_keys_str_mv AT hamayat 821biopsyprovenfulminantmyocarditisrequiringmechanicalcirculatorysupportfollowingthirddoseofcovid19mrnavaccination
AT satot 821biopsyprovenfulminantmyocarditisrequiringmechanicalcirculatorysupportfollowingthirddoseofcovid19mrnavaccination
AT kobayashiy 821biopsyprovenfulminantmyocarditisrequiringmechanicalcirculatorysupportfollowingthirddoseofcovid19mrnavaccination
AT moriy 821biopsyprovenfulminantmyocarditisrequiringmechanicalcirculatorysupportfollowingthirddoseofcovid19mrnavaccination
AT kamiyak 821biopsyprovenfulminantmyocarditisrequiringmechanicalcirculatorysupportfollowingthirddoseofcovid19mrnavaccination
AT otsukan 821biopsyprovenfulminantmyocarditisrequiringmechanicalcirculatorysupportfollowingthirddoseofcovid19mrnavaccination
AT nagait 821biopsyprovenfulminantmyocarditisrequiringmechanicalcirculatorysupportfollowingthirddoseofcovid19mrnavaccination
AT anzait 821biopsyprovenfulminantmyocarditisrequiringmechanicalcirculatorysupportfollowingthirddoseofcovid19mrnavaccination